The Latest Cardiac and Vascular News
Latest grant is the 9th awarded to Dascena from the National Institute of Health SAN FRANCISCO–(BUSINESS WIRE)–Dascena, a developer of machine learning diagnostic algorithms to enable early disease intervention and improved care outcomes for patients, has received a grant from the National Institute on Minority Health and Health Disparities (part of the National […]
Virtual-First Cardiology Company, Heartbeat Health, Achieves SOC 2® Security Control Compliance Certification, Reinforcing Its Commitment to Healthcare Data Security & Privacy. NEW YORK, March 07, 2022 (GLOBE NEWSWIRE) — Heartbeat Health, a Virtual-First Cardiology company that leverages data, device connectivity, and clinicians to deliver on-demand cardiovascular services, announced today that […]
– The breakthrough approval expands the existing indication of Jardiance® to include adults with heart failure with preserved ejection fraction (HFpEF), an underserved patient population that previously had no approved therapies in Europe – European marketing authorization follows the U.S. Food and Drug Administration (FDA)’s approval received on 24 February 2022 […]
S-CATH™ M is the only rapid-response, high-density esophageal temperature probe that is visible on 3D cardiac mapping systems. ENGLEWOOD, Colo., March 3, 2022 /PRNewswire/ — CIRCA Scientific, Inc. announced today that its S-CATH™ M Esophageal Temperature Probe is now cleared for sale in the United States. The new S-CATH M Probe can be […]
VALHALLA, N.Y., March 2, 2022 /PRNewswire/ — Retia Medical today announced that it received a Declaration of Compatibility from Philips for its Argos Cardiac Output Monitor to interface with Philips IntelliBridge system on the IntelliVue patient monitoring systems. The Argos Monitor is now a compatible and “supported device” for Philips IntelliVue Patient […]
DENVER and WASHINGTON, March 2, 2022 /PRNewswire/ — DispatchHealth, the nation’s first comprehensive in-home high acuity medical provider, today announced its collaboration with The American College of Cardiology (ACC), a nonprofit professional medical society, to enhance the lives of cardiovascular disease patients. The first of its kind, the collaboration between DispatchHealth and ACC is designed to […]
Cohort 4 to Enroll Patients with Non-Obstructive Hypertrophic Cardiomyopathy SOUTH SAN FRANCISCO, Calif., March 02, 2022 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the opening of enrollment in Cohort 4 of REDWOOD-HCM (Randomized Evaluation of Dosing With CK-274 in Obstructive Outflow Disease in HCM), an ongoing Phase 2 clinical trial of aficamten, an investigational next-generation cardiac […]
The TicWatch GTH Pro features Arty® Heart Health technology, powered by ATCOR, a subsidiary of CardieX, to monitor arterial and heart health IRVINE, Calif. and SYDNEY, March 1, 2022 /PRNewswire/ — Mobvoi Inc., a leading artificial intelligence-wearable company backed by Google™ and Volkswagen, in partnership with global health tech company CardieX, today announces the launch of […]
– Adults hospitalized for acute heart failure were 36% more likely to experience a clinical benefit over 90 days if initiated on Jardiance after stabilization and before discharge compared with placebo – The benefit was consistent in adults with new or existing heart failure and in those with either preserved […]
SUNNYVALE, Calif., March 01, 2022 (GLOBE NEWSWIRE) — BioCardia®, Inc. (Nasdaq: BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced that it has received a No Objection Letter from Health Canada, the country’s health services agency, allowing the CardiAMP® Heart Failure Trial to […]
